Oracle CORP Form 4 insider transactions

NYSE
Oracle Corp. Director William G. Parrett reported a planned future sale of 11,500 shares of common stock at $306 per share under a Rule 10b5-1 plan.
NYSE
Oracle's President of OCI, Clayton M. Magouyrk, reported selling common stock and vesting restricted stock units.
NYSE
Oracle's President of OCI, Clayton M. Magouyrk, reported the vesting of 62,500 restricted stock units and the subsequent sale of shares to cover tax liabilities.
NYSE
Oracle's President of Industries, Michael D. Sicilia, reported recent stock acquisitions, sales, and RSU vesting, adjusting his beneficial ownership.
NYSE
Oracle's EVP and Chief Accounting Officer, Maria Smith, converted 3,375 restricted stock units into common stock and subsequently sold 1,759 shares to cover tax liabilities.
NYSE
Jeffrey Henley, Oracle's Vice Chairman, reported the acquisition of shares through RSU vesting and a sale to cover tax obligations.
NYSE
Oracle's EVP and Chief Legal Officer, Stuart Levey, reported the acquisition of 164.522 restricted stock units representing deferred dividend equivalents.
NYSE
Oracle Corporation Director Naomi O. Seligman sold 3,303 shares of common stock at $233.32 per share, a transaction executed under a Rule 10b5-1 pre-planned trading arrangement.
NYSE
Oracle's Executive Chairman and CTO, Lawrence Joseph Ellison, exercised stock options to acquire 6.5 million shares of common stock at $51.13 per share, following the certification of performance goals by the Compensation Committee.
NYSE
Lawrence Joseph Ellison, Oracle's Executive Chairman and Chief Technology Officer, exercised 6 million performance-based stock options valued at over $306 million, significantly increasing his direct beneficial ownership in the company.
NYSE
Oracle Corp Director Rona Alison Fairhead purchased 480 shares of common stock at $233.87 per share on July 7, 2025, increasing her direct and indirect beneficial ownership.
NYSE
Oracle's EVP and Chief Accounting Officer, Maria Smith, sold 10,000 shares of common stock for approximately $2.33 million under a Rule 10b5-1 plan.
NYSE
Oracle CEO Safra Catz reported the exercise of stock options and subsequent sale of 1,260,508 shares of Oracle common stock on June 27, 2025, executed under a Rule 10b5-1 trading plan.
NYSE
Oracle Chief Executive Officer Safra Catz executed significant stock option exercises and subsequent sales of over 3.7 million shares of Oracle common stock in late June 2025, as part of a pre-arranged Rule 10b5-1 trading plan.
NYSE
Oracle Executive Chairman and CTO Lawrence J. Ellison has acquired 5 million performance-based stock options, vesting upon the Compensation Committee's certification of a performance goal.
NYSE
Oracle Vice Chairman and Director Jeffrey Henley disclosed gifting 147,000 shares of Oracle common stock on June 23, 2025, as detailed in a recent SEC Form 4 filing.
NYSE
Oracle Corporation CEO Safra Catz executed significant stock option exercises and subsequent sales of over 3.6 million shares, realizing substantial profits under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Oracle Corporation Director George H. Conrades has sold 8,169 shares of common stock for approximately $1.74 million in a pre-arranged transaction.
NYSE
Clayton M. Magouyrk, President of Oracle Cloud Infrastructure (OCI), sold 15,000 shares of Oracle Corp. common stock for approximately $3.2 million, executed under a Rule 10b5-1 trading plan.
NYSE
Oracle Corporation's Vice Chairman and Director, Jeffrey Henley, completed a pre-arranged exercise of stock options and subsequent sale of 400,000 shares of common stock on June 12, 2025, under a Rule 10b5-1 trading plan.
NYSE
Oracle Corp. Director William G. Parrett reported the acquisition of 2,986 shares of common stock through Restricted Stock Unit conversion and the grant of 2,114 new Restricted Stock Units.
NYSE
Oracle Corporation Director Bruce R. Chizen has reported recent transactions involving the acquisition of common stock and restricted stock units, increasing his direct and indirect beneficial ownership.
NYSE
Oracle Director Naomi O. Seligman reported the acquisition of common stock through Restricted Stock Unit (RSU) conversion and the disposition of a larger block of common stock, alongside a new RSU grant.
NYSE
Oracle Corporation Director Leon E. Panetta has reported the acquisition of 2,986 shares of common stock through the settlement of restricted stock units and the grant of an additional 2,114 restricted stock units, as detailed in a recent SEC Form 4 filing.
NYSE
Oracle Corp. Director Charles W. Moorman reported the acquisition of common stock through restricted stock unit vesting and the disposition of a significant number of shares, as detailed in a recent SEC Form 4 filing.
NYSE
Oracle Director Rona Alison Fairhead reported the acquisition of common stock through RSU vesting and the disposition of shares for tax purposes, along with new RSU grants, as detailed in a recent Form 4 filing.
NYSE
Oracle Director George H. Conrades reported the sale of 46,625 shares of common stock, alongside the exercise of 2,986 restricted stock units and the grant of 2,114 new restricted stock units.
NYSE
Oracle Corp. Director Michael J. Boskin reported the exercise of restricted stock units, acquisition of new units, and a substantial sale of common stock on May 31, 2025.
NYSE
Oracle Corporation Director Jeffrey Berg has reported the acquisition of 2,986 shares of common stock through the conversion of restricted stock units and an additional 2,114 restricted stock units, executed under a pre-arranged trading plan.
NYSE
Oracle Corporation Director Ablo Awo reported the conversion of restricted stock units into common stock, a new RSU grant, and shares withheld for tax liability, as detailed in a recent SEC Form 4 filing.